QuidelOrtho Corp. (QDEL)
12.42
+0.11
(+0.89%)
USD |
NASDAQ |
Oct 08, 16:00
12.42
0.00 (0.00%)
After-Hours: 20:00
QuidelOrtho Enterprise Value : 3.793B for Oct. 7, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 07, 2026 | 3.793B |
| October 06, 2026 | 3.811B |
| October 05, 2026 | 3.781B |
| October 02, 2026 | 3.688B |
| October 01, 2026 | 3.661B |
| September 30, 2026 | 3.672B |
| September 29, 2026 | 3.676B |
| September 28, 2026 | 3.692B |
| September 25, 2026 | 3.699B |
| September 24, 2026 | 3.682B |
| September 23, 2026 | 3.658B |
| September 22, 2026 | 3.699B |
| September 21, 2026 | 3.694B |
| September 18, 2026 | 3.677B |
| September 17, 2026 | 3.709B |
| September 16, 2026 | 3.688B |
| September 15, 2026 | 3.678B |
| September 14, 2026 | 3.711B |
| September 11, 2026 | 3.757B |
| September 10, 2026 | 3.782B |
| September 09, 2026 | 3.815B |
| September 08, 2026 | 3.866B |
| September 04, 2026 | 3.906B |
| September 03, 2026 | 3.903B |
| September 02, 2026 | 3.905B |
| Date | Value |
|---|---|
| September 01, 2026 | 3.891B |
| August 31, 2026 | 3.938B |
| August 28, 2026 | 3.959B |
| August 27, 2026 | 3.998B |
| August 26, 2026 | 3.970B |
| August 25, 2026 | 3.980B |
| August 24, 2026 | 3.942B |
| August 21, 2026 | 3.959B |
| August 20, 2026 | 3.966B |
| August 19, 2026 | 3.895B |
| August 18, 2026 | 3.869B |
| August 17, 2026 | 3.948B |
| August 14, 2026 | 3.929B |
| August 13, 2026 | 3.983B |
| August 12, 2026 | 3.965B |
| August 11, 2026 | 3.908B |
| August 10, 2026 | 3.891B |
| August 07, 2026 | 3.791B |
| August 06, 2026 | 4.067B |
| August 05, 2026 | 4.147B |
| August 04, 2026 | 4.153B |
| August 03, 2026 | 4.162B |
| July 31, 2026 | 4.097B |
| July 30, 2026 | 4.084B |
| July 29, 2026 | 4.079B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| IDEXX Laboratories, Inc. | 40.86B |
| Neogen Corp. | 3.150B |
| Aspira Women's Health, Inc. | 14.75M |
| VolitionRX Ltd. | 9.967M |
| Lucid Diagnostics, Inc. | 110.44M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -92.90M |
| Revenue (Quarterly) | 630.20M |
| Total Expenses (Quarterly) | 723.10M |
| EPS Diluted (Quarterly) | -1.360 |
| Gross Profit Margin (Quarterly) | 35.75% |
| Profit Margin (Quarterly) | -14.74% |
| Earnings Yield | -124.1% |
| Normalized Earnings Yield | -57.83 |